Answer questions and earn CME/CNE The heterogeneity and complexity of advanced
cancers strongly support the rationale for an enhanced focus on molecular prevention as a …

SERMs represent a diverse group of molecules with varying levels of estrogenic agonist and
antagonist activity in target tissues. SERMs have a long regulatory approval history and …

Atypical Hyperplasia of the Breast — Risk Assessment and Management Options | New England
Journal of Medicine Skip to main content The New England Journal of Medicine homepage …

Medicinal Chemistry of Anticancer Drugs, Second Edition, provides an updated treatment
from the point of view of medicinal chemistry and drug design, focusing on the mechanism of …

BACKGROUND AND OBJECTIVES: To provide guidelines for medical professionals in
Saudi Arabia regarding osteoporosis. DESIGN AND SETTINGS: A panel of 14 local experts …

Traditional menopausal hormone therapy containing estrogens/progestin has been
associated with an increased risk of breast cancer, and estrogen exposure is known to …

During the past 20 years our understanding of the control of breast tumor development,
growth and survival has changed dramatically. The once long forgotten application of high …

Over the past three decades great efforts have been made in search of cancer
chemoprevention strategies. The increase in knowledge of the long process from normal to …

Aim The aim was to examine the anti-proliferative effect of a Withania somnifera (WS) root
extract in cell cultures and nude mouse xenografts of breast cancer cell line MDA-MB-231 …

Breast cancer is the most common cancer in women with 232,670 new cases estimated in
the USA for 2014. Approaches for reducing breast cancer risk include lifestyle modification …